Previous 10 | Next 10 |
Adial Pharmaceuticals ([[ADIL]] +4.7%) receives a notice of allowance for its third U.S. patent relating to the use of AD04 for the treatment of opioid use disorder.The patent covers the use of the company's lead product, AD04, as a treatment of opioid use disorder in patients ...
CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ( "Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that William Stilley, Chief Executive Officer...
CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced receipt of a Notice of Allowance for its third U.S. patent relating to t...
ONWARD™ Trial Remains on Track to be Fully Enrolled During Q2 2021 CHARLOTTESVILLE, VA / ACCESSWIRE / December 17, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today a...
CHARLOTTESVILLE, VA / ACCESSWIRE / December 15, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced the appointment of Dr. Jack Reich as Head of Regulatory, effective...
CHARLOTTESVILLE, VA / ACCESSWIRE / December 10, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ("Adial"), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced that it will host a conference call at 11:00 AM, Eastern Time ...
Adial Pharmaceuticals ([[ADIL]] +5.0%) has entered into a definitive agreement to acquire Purnovate, LLC , a pharmaceutical development company.Purnovate is focused on novel, drug candidates for non-opioid pain reduction and the treatment of addiction and other diseases through targeted use o...
CHARLOTTESVILLE, VA / ACCESSWIRE / December 10, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ( "Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it has entered into a definitive agreem...
CHARLOTTESVILLE, VA / ACCESSWIRE / December 9, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today issued a public statement encouraging those battling alcohol and other substance u...
Previous news segment has appeared on dozens of media stations nationwide CHARLOTTESVILLE, VA / ACCESSWIRE / December 4, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, reports th...
News, Short Squeeze, Breakout and More Instantly...
Adial Pharmaceuticals Inc Company Name:
ADIL Stock Symbol:
NASDAQ Market:
Adial Pharmaceuticals Inc Website:
2024-07-24 06:29:00 ET 3 Top Tips for Building a Penny Stocks Watchlist Investing in penny stocks can offer exciting opportunities for significant returns with a relatively small initial investment. Building a robust penny stocks watchlist is essential for identifying potential winn...
A look at the top 10 most actives in the United States SunPower Corporation (SPWR) rose 31.3% to $0.9396 on volume of 186,118,381 shares Selina Hospitality PLC (SLNA) fell 29.7% to $0.026 on volume of 168,426,091 shares NVIDIA Corporation (NVDA) fell 0.8% to $122.59 on volume of 168,211,0...
A look at the top 10 most actives in the United States Agape ATP Corporation (ATPC) rose 112.1% to $0.3033 on volume of 62,336,784 shares Warrantee Inc. (WRNT) rose 27.8% to $0.372 on volume of 55,635,565 shares Adial Pharmaceuticals Inc (ADIL) rose 110.3% to $2.2295 on volume of 54,549,4...